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Abstract—This study aims to employ in vivo manganese-
enhanced MRI (MEMRI) to detect neurodegenerative changes 
in two models of brain ischemia, photothrombotic cortical 
injury (PCI) and transient middle cerebral artery occlusion 
(MCAO) in rodents. After systemic Mn2+ injection to both 
ischemic models, a close pattern of T1-weighted hyperintensity 
was observed throughout different brain regions in comparison 
to the distribution of GFAP, MnSOD and GS 
immunoreactivities, whereby conventional MRI could hardly 
detect such. In addition, the infarct volumes in the posterior 
parts of the brain had significantly reduced after Mn2+ injection 
to the MCAO model. It is suggested that exogenous Mn2+ 
injection may provide enhanced MEMRI detection of oxidative 
stress and gliosis early after brain ischemia. Manganese may 
also mediate infarctions at remote brain regions in transient 
focal cerebral ischemia before delayed secondary damage takes 
place. 
I. INTRODUCTION 
ANGANESE (Mn) is an essential constituent of two 
important metalloproteins involved in the 
pathophysiology of cerebral hypoxia and ischemia. Mn 
binds to the mitochondrial Mn-superoxide dismutase 
(MnSOD) enzyme, which acts against cellular oxidative 
stress. It also binds to glutamine synthetase (GS), which is a 
glial specific enzyme for regulating extracellular glutamate 
and reducing glutamate excitotoxicity. In experimental 
animal models of stroke, delayed hyperintensity was found in 
T1-weighted images (T1WI) due to MnSOD accumulation at 
the ischemic core [1], whereas upon exogenous Mn2+ 
injection to neonatal rat models of hypoxic-ischemic 
encephalopathy, upregulation of MnSOD and GS activities 
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was observed, leading to Mn-enhanced MRI (MEMRI) 
detection of lesions undetectable by other MR modalities [2, 
3]. Given a previous study indicating a transient increase of 
MnSOD in remote brain areas after focal photothrombotic 
cortical injury (PCI) [4], a relatively non-invasive and 
reproducible model for stroke, this study aims to employ in 
vivo MEMRI to detect transient changes in adult rat model 
of PCI in different brain regions. Further, given the previous 
reports on the role of manganese as an antioxidant after 
manganese chloride administration to animals [5, 6], we 
attempted to test the feasibility of mediating remote 
infarction by delayed administration of manganese after 
transient middle cerebral artery occlusion (MCAO), in 
addition to the reproducibility of enhanced MEMRI 
detection of neurodegeneration in brain ischemia to different 
strains of rodents.  
II. MATERIALS AND METHODS 
A. Animal Preparation 
Adult Sprague-Dawley rats (200-250 g, N=8) and adult 
C57BL/6N mice (18-22 g, N=8) were subjected to PCI in the 
motor cortex center [4] and 30 min-transient MCAO [7], 
respectively, and were divided into 4 groups (N=4 each). 
Two days after surgery, PCI rats in Group 1 and MCAO 
mice in Group 3 were administered with an intraperitoneal 
injection of MnCl2 solution (45 mg/kg, 100 mM), while the 
other animals in Groups 2 and 4 received no injection. MRI 
was performed to the PCI animals at 3, 7, 14 and 21 days 
after surgery, whereby 2 rats from each group were 
sacrificed for histology after MR examinations at Day 7. 
MEMRI was also performed on 3 additional normal rats 
before, 1 day and 5 days after Mn2+ injection to compare 
with the PCI groups at the corresponding time points with 
and without Mn2+ administration. For MCAO animals, MRI 
was performed at 3, 7, 10, 14, 21 and 150 days after surgery, 
whereby 2 mice from each group were sacrificed for 
histology after MR examinations at Day 10.  
B. MRI Protocols  
All MRI measurements were acquired on a 7T Bruker 
scanner. Under inhaled isoflurane anaesthesia (3% induction 
and 1.5% maintenance), the animals were kept warm under 
circulating water at 37 oC, and were imaged using a receive-
only surface coil for the PCI model, and a mouse brain 
quadrature resonator for the MCAO model. 2D T1-weighted 
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(T1W) RARE sequence was acquired with TR/TE = 400/7.5 
ms, RARE factor = 4, and matrix resolution = 256x256. For 
PCI model, FOV = 3.2 x 3.2 cm2, slice thickness = 1 mm, 
and NEX = 16. For MCAO model, FOV = 2.0 x2.0 cm2, 
slice thickness = 0.7 mm, and NEX = 20. T2-weighted 
imaging (T2WI) was performed under the same dimensions 
with TR/TE = 6500/120 ms, RARE factor = 12, and NEX = 
2 and 4 respectively for PCI and MCAO. Spin-echo EPI 
diffusion weighted images (DWI) were acquired with TR/TE 
= 3000/28 ms, matrix resolution = 128x128, NEX = 4, b = 0 
and 100 s/mm2, number of shots = 4 and 30 diffusion 
directions. FOV = 3.2 x 3.2 cm2 for PCI model and 3.0 x 3.0 
cm2 for MCAO model. 
C. Data Analysis 
The T1W signal intensities at the hypointense ischemic 
core and peri-infarct areas 0.5 mm to the core border were 
measured in both ischemic models using ImageJ v1.38x 
(Wayne Rasband, NIH, USA). The total brain volumes, and 
the total infarct volumes indicated by T2W hyperintensity 
were also measured in the ipsilesional side of the brain. 
Mean values were compared using two-tailed Student’s t-
tests, and the values along the time course were compared 
using ANOVA. Results were considered to be significantly 
different when p<0.05. 
D. Histology 
After MR examinations, the animals were transcardially 
perfused with 4% paraformaldehyde. The brains were then 
removed, cut into 10 µm sections, and immunostained for 
glial fibrillary acdic protein (GFAP), manganese superoxide 
dismutase (MnSOD) and glutamine synthetase (GS), which 
are markers for gliosis, oxidative stress and glutamate 
excitotoxicity, respectively. 
III. RESULTS 
A. Enhanced MEMRI detection in PCI model 
When no Mn2+ was applied to the PCI animals in Group 2, 
the dynamic changes of T2WI and DWI abnormalities 
generally followed as previously described [8]. At Day 3 
after photothrombosis, no T1W signal enhancement was 
observed in the PCI model at the ipsilesional perilesional rim 
(p>0.05) as in Figure 1. Yet at Day 7 when the MnSOD 
activity was supposed to peak in the peri-infarct areas [4], 
mild T1W signal enhancement was observed at the 
perilesional rim upon windowing. However, such increase 
was not statistically significant when compared to the same 
regions in the normal rats before Mn2+ injection (p>0.05), 
even though MnSOD and GS immunoreactivities were 
observed in the ipsilesional cortex as in Figure 2. The 
apparent T1W signals then dropped as time went by.  
After Mn2+ injection, T1W hyperintensity was observed at 
the perilesional rims in all animals. At Day 3 and Day 7 after 
photothrombosis, animals in Group 1 gave a significant 
increase in signal intensities at the rims compared to the 
 
Fig. 1. Typical T1WI at the center of ischemic core at 3 and 7 days after 
photothrombosis, showing hyperintensity in the perilesional rims (arrows) 
with (Group 1) and without (Group 2) Mn2+ injection. Hyperintensity was 




Fig. 2.  T1WI at the ischemic core at Day 7 following photothrombosis with 
(Group 1) and without (Group 2) Mn2+ injection, and the corresponding 
GFAP, MnSOD and GS immunohistochemical stains at Day 7. Note also 
the enhancement in the ipsilesional thalamus in Group 1 (arrow). 
 
 
Fig. 3. (Top) Typical T1WI of a normal rat (a) before and (b) 24 hours after 
Mn2+ injection. (Bottom) Typical T1WI at about 2 mm anterior to the 
ischemic core at (c) 3 days and (d) 7 days after photothrombosis, showing 
hyperintensity in the ipsilesional cortex (arrows) after Mn2+ injection at day 
2 in Group 1. 
 
 
Fig. 4.  Mn-enhanced MRI of the striatum at 3, 7 and 10 days following 
MCAO in Group 3, and the corresponding GFAP, MnSOD and GS 
immunohistochemical stains at Day 10. 
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same location in both the Group 2 animals without Mn2+ 
injection (p<0.05), and the normal rats after Mn2+ 
administration (p<0.05). Enhancement could also be found 
in the ipsilesional cortex distinct from the ischemic core 
in Figure 3 and occasionally the subcortical regions in 
Figures 2 and 3 compared to the normal brains after Mn2+ 
administration. 
B. Enhanced MEMRI detection in MCAO model 
In the ipsilesional dorsolateral striatum, when no Mn2+ 
was applied in the MCAO mice in Group 4, signal intensity 
increased in T1WI (ANOVA, p<0.01) and decreased in 
T2WI (ANOVA, p<0.01) from Day 3 to Day 21 after 
MCAO. These were in agreement with previous studies 
suggestive of delayed ischemic striatal neurodegeneration [1] 
and inflammatory responses [9]. The diffusion trace values 
had also dropped in the corresponding hyperintense regions 
in T2WI, indicative of the presence of oedema. At Day 3, a 
significant increase in signal intensity at the perilesional rim 
was observed in T1WI compared to the ischemic core in 
Group 3 after Mn2+ injection for 24 hours (paired t-test, 
p<0.05) but not Group 4 (p=0.18), while the Mn-enhanced 
MRI pattern at Day 10 was in good colocalization with 
GFAP, MnSOD and GS immunostainings in Figure 4.  
C. Total infarct volumes in PCI and MCAO models 
The infarct volumes indicated by hyperintense regions in 
T2WI dropped significantly in both models as time went by. 
The total infracted volumes in ipsilesional forebrain were not 
different between the two MCAO groups as in Figure 5. 
However, in the brain regions remote to the ischemic core, 
T2W hyperintensity was observed in the hippocampus, 
thalamus, midbrain and superior and inferior colliculi in all 
mice in Group 4, while mild infarction could only be found 
in the thalamus of one of the mice in Group 3. As shown in 
Figure 6, total infracted volumes in the posterior parts of the 
ipsilesional brain had significantly reduced after Mn2+ 
injection. Note that at 150 days after MCAO, shrinkage of 
the midbrain and the superior and inferior colliculi was 
observed in all the 2 remaining animals in Group 4 but not 
Group 3 as shown in Figure 7. No significant difference was 
observed in the total infarct volumes between Group 1 and 
Group 2 in the PCI model.   
IV. DISCUSSIONS 
In the present study we demonstrated the early detection 
of neurodegeneration in brain ischemia by MEMRI in both 
PCI and MCAO models of different animal strains. These 
patterns were in good colocalization with GFAP, MnSOD 
and GS stains and with literature [1, 4]. It was found that 
astroglial cells highly immunostained for GFAP would 
secrete reactive oxygen species, resulting in an upregulation 
of MnSOD and GS [2, 10], which are Mn dependent 
enzymes. In addition, glutamate could be released at the peri-
infarct areas by increasing the activation of neuronal 
 
Fig. 5.  (Top) Typical T2WI at Bregma -0.58 mm, showing hyperintensity 
in the ipsilesional dorsolateral striatum (arrows) with (Group 3) and without 
(Group 4) Mn2+ injection. (Bottom) Total infarct volumes indicated by 
T2W hyperintensity between Bregma -1.70 mm and 1.54 mm in the 




Fig. 6.  (Top) Typical T2WI at Begma -3.08, showing hyperintensity in the 
ipsilesional midbrain and hippocampus (arrow) in Group 4 but not Group 
3. (Bottom) Total ipsilesional infarct volumes in the posterior part of the 
brain between Bregma – 4.96 mm and -1.70 mm had significantly reduced 
after Mn2+ injection (unpaired t-tests between two groups on infarct 
volumes (black) or non-infarct volumes (white), ** p<0.01, * p<0.05) 
 
 
Fig. 7. Axial T2WI of mouse brains at 150 days after MCAO. An apparent 
shrinkage of the ipsilesional midbrain (arrow) was observed in all the 2 
animals remained in Group 4 compared to Group 3. 
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glutamate receptors which in turn increased membrane 
permeability to Ca2+ in astrocytes [11-13]. Given Mn2+ has 
been demonstrated as a calcium analog [14], it is possible 
that exogenous Mn2+ injection would lead to enhanced 
MEMRI detection of oxidative stress and gliosis [2, 5]. Note 
that hyperintense signal areas in MEMRI were shown to 
match perfectly with areas of microglial activation in the 
transgenic mouse brains at terminal disease stage [15]. 
On the other hand, it has been recognized that brain 
regions remote to the striatum were less susceptible to 
oxidative stress [16] and might undergo later onsets for 
delayed neuronal death due to ischemia and reperfusion [17].  
Microglial reaction at remote sites such as the neocortex, 
thalamus and both hippocampi took about 5 days to become 
fully apparent after transient focal cerebral ischemia [18], 
whereas brain macrophages were clearly visible at 3-7 days 
postischemia [19]. Previous MEMRI studies have shown that 
Mn2+ accumulated and gave peak enhancements in T1WI in 
the posterior parts of the mouse brain within 24 hours after 
systemic Mn2+ administration [20]. Given that Mn2+ 
triggered the scavenging of superoxide and hydroxyl radicals 
[5], whereby MnSOD and GS activities increased upon 
MnCl2 administration to normal and ischemic animals [2, 5, 
6], it is possible that the reduction in infarct volumes in 
T2WI in the posterior parts of the MCAO mice might be 
associated with neuroprotection of Mn2+ at remote sites 
before apparent delayed secondary damage took place, 
though further analyses are needed to address this issue. 
Note also the less neuronal shrinkage in the midbrain areas 
of the mice in all the 2 remaining animals in Group 3 when 
compared to those in Group 4 at 5 months after MCAO in 
Figure 7. Recent studies have shown marked neuroprotective 
effects of manganese complexes against focal ischemic 
insults up to 6 hours after ischemia [21, 22]. The results of 
this study illustrated the potential neuroprotective effects of 
manganese after administration at a longer postischemic 
delay. No significant difference was observed in the infarct 
areas in the forebrain of MCAO mice or the PCI rats 
between groups with and without Mn2+ injection, possibly 
due to the ischemic core being readily damaged before Mn2+ 
administration. 
V. CONCLUSIONS 
Given the distribution of T1W hyperintensity was similar 
to that of MnSOD and GS immmunoreactivities reported [2, 
4], it is likely that exogenous Mn2+ injection may provide 
enhanced MEMRI detection of oxidative stress and gliosis 
early in the PCI and MCAO models of different strains. 
Manganese may also mediate remote brain infartions in 
transient focal cerebral ischemia before delayed secondary 
damage takes place. 
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